Statements (48)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:physicist
|
gptkbp:bfsLayer |
5
|
gptkbp:bfsParent |
gptkb:Sheltie
gptkb:Weimaraner |
gptkbp:affects |
blood clotting
|
gptkbp:associated_with |
gptkb:healthcare_organization
gptkb:von_Willebrand_factor thrombocytopathy platelet dysfunction |
gptkbp:caused_by |
deficiency of von Willebrand factor
|
gptkbp:clinical_trial |
bleeding gums
nosebleeds post-surgical bleeding petechiae heavy menstrual periods |
gptkbp:complications |
gastrointestinal bleeding
joint bleeding menorrhagia |
gptkbp:descendant |
autosomal dominant
|
gptkbp:first_described_by |
1926
|
https://www.w3.org/2000/01/rdf-schema#label |
von Willebrand's disease
|
gptkbp:is_popular_in |
1% of the population
|
gptkbp:manager |
patient education
regular check-ups avoidance of certain medications |
gptkbp:named_after |
gptkb:Erik_von_Willebrand
|
gptkbp:research_focus |
gptkb:physicist
understanding pathophysiology new treatments |
gptkbp:risk_factor |
gptkb:hospital
family history pregnancy certain medications |
gptkbp:social_responsibility |
blood tests
ristocetin cofactor activity bleeding history von Willebrand factor levels |
gptkbp:symptoms |
easy bruising
excessive bleeding prolonged bleeding after injury |
gptkbp:treatment |
desmopressin
factor replacement therapy hormonal therapy antifibrinolytics avoidance of contact sports |
gptkbp:type |
gptkb:Type_3
Type 1 Type 2 |